Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.
According to a press statement, the following organisations will collaborate to develop and test AI for identifying novel drug candidates and predicting its efficacy:
DAAN Cancer Research Institute under Yonsei...
Neurophet sets up China JV
Medical imaging AI company Neurophet from South Korea has established a joint venture in China.
It recently signed an exclusive deal with LADO, one of the leading medical software providers in China, to market its AI-based software for quantifying levels of Alzheimer's disease biomarkers in PET images.
The deal, which also establishes a joint venture with LADO, aims...
South Korean medical AI company AITRICS has obtained clearance from the Ministry of Health, Vietnam for its AI software for predicting patient deterioration.
VitalCare utilises AI to analyse 19 types of EMR data of patients in general wards to predict possible death, ICU transfer, and cardiac arrest within six hours. It can also predict sepsis within four hours, cardiac arrest within 24 hours, as...
Biofourmis founder launches health LMM startup
Over a year after leaving biotechnology unicorn Biofourmis, ex-CEO and founder Kuldeep Singh Rajput recently announced that he set up a new health tech company focused on generative AI.
In a LinkedIn post, he shared that his newly founded startup, OutcomesAI, has partnered with SingHealth to deploy its large multi-modal model (LMM) called Glia,...
Mental health app Lissun bags $3M for AI integration
Mental health platform Lissun in India has scored $2.5 million in a pre-Series A funding round led by RPSG Capital Ventures.
With its fresh funds, the startup plans to integrate AI into its suite of digital mental health solutions which target corporates, schools, and families of children with neurodevelopmental conditions. The new funds will...
Qure.ai nets $65M for foundational AI
Qure.ai has raised $65 million in a Series D funding round led by Lightspeed and 360 ONE Asset.
The company said it will use its fresh funds to invest more in foundational AI models, as well as acquire complementary startups in medical technology. It will also be used to accelerate its expansion in the United States and other markets.
Early this year, the...
Respiree, Roche announces AI integration for RPM
Singaporean startup Respiree has tied up with global pharmaceutical and diagnostics company Roche for technology integration.
Respiree will be combining its vital sign monitoring device with Roche's blood glucose device as a joint bedside offering. The solution is also expected to be integrated with machine learning models that predict clinical...
A new mental health diary app developed in South Korea leverages generative AI to early screen depression while securing sensitive user data.
HOW IT WORKS
Doctorpresso came up with a mobile app called REDI that analyses a user's speech patterns and provides near real-time insights into their mental state.
Through AI, the app analyses four voice characteristics: average pitch, pitch variability...
Pharmaceutical and diagnostics giant Roche has recently integrated a suite of AI algorithms into its enterprise digital pathology software.
The company has collaborated with South Korean firm Deep Bio to power the navify digital pathology platform with the prostate cancer analysis AI solution, DeepDx Prostate. The AI technology provides pathologists with gland-level Gleason grading, measurements...
